They've clearly had trouble with production of DX-1, which company in their right mind would do a deal for DX-3 when it is behind DX-1 in terms of production, and DX-1 hasn't even completed phase 1 first. Makes no sense.
Ann: Presentation to highlight broader potential of Deoxymabs, page-45
-
- There are more pages in this discussion • 45 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $12.34M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 1283356 | 0.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.7¢ | 4958674 | 5 |
View Market Depth
| Last trade - 16.12pm 27/09/2024 (20 minute delay) ? |
| PAB (ASX) Chart |
Day chart unavailable